IL2 and early-onset autosomal dominant Alzheimer disease: Dysregulation of interleukin-2 (IL-2) has been implicated in the pathogenesis of neurological and neuropsychiatric disorders including multiple sclerosis, Alzheimer’s disease and schizophrenia [1,2].